Related Experiment Video
Updated: Oct 18, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Lack of cyclooxygenase-2 inhibits growth of teratocarcinomas in mice
X Zhang1, S G Morham, R Langenbach
1E. Henry Keutmann Laboratory, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Abstract:
Two isoforms of cyclooxygenase (COX-1 or COX-2) have been identified in the prostanoid biosynthetic pathway. The constitutive form, COX-1, is thought to maintain cellular homeostasis and the inducible form, COX-2, is recognized as a primary response gene thought to be involved in modulating cell proliferation and differentiation. To further characterize the role of the cyclooxygenases in cell proliferation, differentiation, and tumorigenicity we developed embryonic stem (ES) cell lines which contain homozygous disruptions in either the COX-1 or the COX-2 gene. These lines were then examined in terms of their viability, proliferation, and in vitro differentiation potential. Our results demonstrate that the wild-type ES cells do not express either COX-1 or COX-2 until the cells undergo differentiation. And the lack of either cyclooxygenase has no apparent effect on ES cell proliferation in vitro. However, the absence of a functional COX-2 gene leads to a dramatic reduction in the formation and growth of teratocarcinomas that appear when ES cells are injected into syngeneic mice. Histological microscopy shows that the few very small tumors that were generated from ES cells lacking COX-2 appear more differentiated than tumors emerging from COX-1 -/- or wild-type cells by exhibiting greater keratinization in the areas of squamous epithelium and the ossification of bone-forming cartilage. We conclude that the presence of a functional COX-2 enzyme is necessary for the efficient growth of these teratocarcinomas in animals.
Insights
Cyclooxygenase-2 (COX-2) is essential for teratocarcinoma growth in mice. Disrupting the COX-2 gene significantly reduces tumor formation and promotes differentiation, highlighting its role in tumorigenicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Developmental Biology
Background:
- Cyclooxygenase enzymes, COX-1 and COX-2, are key in prostanoid biosynthesis.
- COX-1 maintains homeostasis, while COX-2 is involved in cell proliferation and differentiation.
- Understanding cyclooxygenase roles in tumorigenicity is crucial for cancer research.
Purpose of the Study:
- To investigate the roles of COX-1 and COX-2 in embryonic stem cell (ES) proliferation, differentiation, and tumorigenicity.
- To characterize the impact of COX gene disruptions on teratocarcinoma development.
Main Methods:
- Development of ES cell lines with homozygous disruptions in COX-1 or COX-2 genes.
- Assessment of ES cell viability, proliferation, and in vitro differentiation potential.
- In vivo analysis of teratocarcinoma formation and growth after ES cell injection into mice.
Main Results:
- Wild-type ES cells express COX-1 and COX-2 upon differentiation, not in undifferentiated states.
- Lack of COX-1 or COX-2 does not affect ES cell proliferation in vitro.
- Absence of functional COX-2 significantly reduces teratocarcinoma formation and growth.
- Teratocarcinomas from COX-2 deficient cells show enhanced differentiation markers like keratinization and ossification.
Conclusions:
- Functional COX-2 is necessary for efficient teratocarcinoma growth in vivo.
- COX-2 plays a critical role in modulating ES cell tumorigenicity and differentiation.
- Targeting COX-2 may offer therapeutic strategies for certain cancers.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Teratogenicity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

